The Food and Drug Administration recently issued warning letters to four major retailers regarding their sales of a recalled infant formula linked to a botulism outbreak. The letter specifically identified Byheart infant formula and highlighted that it remained on store shelves long after the recall.
This notice, released on Friday by the FDA’s Human Food Program, targets Walmart, Target, Kroger, and Albertsons for selling or allowing “adulterated” infant formula, despite ongoing recall notifications and warnings from health officials. This outbreak affected 51 infants across 19 states.
The FDA confirmed that Byheart Whole Nutrition infant formula was responsible for these cases of infant botulism. The bacteria involved, Clostridium botulinum, can produce serious health risks for infants.
It was noted that all infants identified in this outbreak had consumed Byheart formula prior to falling ill.
Byheart initiated a voluntary recall of specific formula batches, which was later expanded to encompass all their infant formula products, including single-use packs, on November 8th and November 11th.
However, the warning letter stated that FDA inspectors, along with state health officials, discovered the recalled formula still being sold across various locations tied to these retailers.
For instance, Walmart had recalled Byheart formula on its shelves in 21 states between November 12 and November 26, even after the recall was issued.
Even after multiple follow-ups, the FDA indicated that Walmart was unable to demonstrate any corrective actions taken.
Target faced a similar situation, with the FDA finding recalled products in 20 states even after the company claimed it had taken steps to block these items electronically.
Kroger reportedly continued to sell the recalled Byheart formula in 10 states, including its affiliated stores like King Soopers and Smith’s, from November 12 to November 19.
Similar issues were observed at Albertsons stores across 11 states, which included its various grocery chains. The FDA claimed that the recalled formula was still available days after the company was informed of the recalls.
A representative from Albertsons emphasized their commitment to customer safety, stating that they removed Byheart products from store shelves and follow established protocols for recalls.
Infant botulism occurs when babies consume spores that can grow in their underdeveloped intestines, creating harmful toxins. Early symptoms may include constipation, poor feeding, and loss of head control, which, in severe cases, can lead to respiratory failure.
The FDA pointed out that symptoms may take time to develop, complicating the identification of contaminated products.
As part of an ongoing investigation, the FDA, along with the CDC and state partners, continues to examine unopened samples of the infant formula. It’s important to note that negative test results do not conclusively rule out contamination due to the scientific challenges involved in detecting the bacteria.
Officials stressed that failing to address these violations could lead to serious consequences such as product seizures or legal actions. Retailers have 15 business days to respond and establish measures to prevent the sale of recalled products moving forward.
The warning letter made it clear that retailers bear responsibility for removing hazardous products once a recall is announced, as immediate removal is crucial to avert further risks.
Byheart has since recalled all its infant formula nationwide, and the investigation regarding the botulism outbreak remains active.
The Post has reached out to Byheart, Kroger, Walmart, and Target for their responses.
